Mapping Acute Lymphoblastic Leukemia (ALL) Subtypes: An Interview with Todd Druley of Mission Bio (Pt. 2)
Photo: Todd Druley, Mission Bio

Mapping Acute Lymphoblastic Leukemia (ALL) Subtypes: An Interview with Todd Druley of Mission Bio (Pt. 2)

Don't forget to read Part 1 of our interview, where Todd discusses what acute lymphoblastic leukemia (ALL) is and why it is so important to raise awareness for ALL and other cancers. Today,…

Continue Reading Mapping Acute Lymphoblastic Leukemia (ALL) Subtypes: An Interview with Todd Druley of Mission Bio (Pt. 2)
Mapping Acute Lymphoblastic Leukemia (ALL) Subtypes: An Interview with Todd Druley of Mission Bio (Pt. 1)
Photo: Todd Druley, Mission Bio

Mapping Acute Lymphoblastic Leukemia (ALL) Subtypes: An Interview with Todd Druley of Mission Bio (Pt. 1)

Did you know that September is Childhood Cancer Awareness Month? Although September has just passed, it is still important to raise awareness of the many different forms of childhood cancer…

Continue Reading Mapping Acute Lymphoblastic Leukemia (ALL) Subtypes: An Interview with Todd Druley of Mission Bio (Pt. 1)
Despite New Rules, Extreme Costs Make Hospitals Balk at Offering the Latest and Greatest Therapies
DarkoStojanovic / Pixabay

Despite New Rules, Extreme Costs Make Hospitals Balk at Offering the Latest and Greatest Therapies

According to a story from statnews.com, new, groundbreaking forms of treatment, such as gene therapy and CAR-T cell therapy, are giving patients with rare genetic disorders and advanced cancers more…

Continue Reading Despite New Rules, Extreme Costs Make Hospitals Balk at Offering the Latest and Greatest Therapies
Early Data Looks Favorable for CAR-T Cell Therapy as a Treatment For Acute Lymphocytic Leukemia
Alexas_Fotos / Pixabay

Early Data Looks Favorable for CAR-T Cell Therapy as a Treatment For Acute Lymphocytic Leukemia

According to a story from finanznachrichten.de, the Korean biopharmaceutical company Biocure Technology, Inc., recently announced the results of a pre-clinical trial that tested CAR-T cell therapy as a treatment for acute…

Continue Reading Early Data Looks Favorable for CAR-T Cell Therapy as a Treatment For Acute Lymphocytic Leukemia